🔎 Trials Near Me

Domov › Akutna mieločna levkemija › Pennsylvania › Philadelphia

Klinične študije za Akutna mieločna levkemija v Philadelphia, PA

34 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Philadelphia in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • Thomas Jefferson University Hospital, Philadelphia
Starost 60 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07437950

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Vključevanje udeležencevFaza 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Children's Hospital of Philadelphia, Philadelphia
Do 21 let · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07012044

Assessment of Geriatric Evaluations Impact on New AML Guidance

Vključevanje udeležencevOpazovalna študija
  • Abramson Cancer Center at University of Pennsylvania, Philadelphia
Starost 50 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05909501

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi stran
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Vključevanje udeležencevOpazovalna študija
  • Children's Hospital of Philadelphia, Philadelphia
Starost 0–38 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06131801

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • Thomas Jefferson University, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • Thomas Jefferson University Hospital, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Vključevanje udeležencevFaza 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi stran
6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Vključevanje udeležencevFaza 1/2
  • University of Pennsylvania, Philadelphia
30 Days · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT04065399

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Vključevanje udeležencevFaza 1
  • UPENN Perelman Center for Advanced Medicine, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06846606

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Vključevanje udeležencevFaza 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi stran
Starost 1–25 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Vključevanje udeležencevFaza 1/2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi stran
Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours Alfred I. Dupont Hospital for Children, Wilmington · 25 mi stran
29 Days – 21 Years · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Vključevanje udeležencevFaza 3
  • University of Pennsylvania, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07007312

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Vključevanje udeležencevFaza 2/3
  • University of Pennsylvania, Philadelphia
Starost 18–80 · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT06788756

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Children's Hospital of Philadelphia, Philadelphia
Starost 1–30 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06177067

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

Vključevanje udeležencevFaza 2
  • Penn Medicine Abramson Cancer Center, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT05442216

CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

Vključevanje udeležencevFaza 1
  • University of Pennsylvania, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 9. jul. 2026 · NCT05945849

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Vključevanje udeležencev
  • Children's Hospital of Philadelphia, Philadelphia
Do 25 let · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT03810196

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Children's Hospital of Philadelphia, Philadelphia
Starost 0–29 · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT07464951

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Vključevanje udeležencevOpazovalna študija
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21 mi stran
Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Vključevanje udeležencevFaza 1/2
  • Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT04068597

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

Vključevanje udeležencevFaza 1
  • University of Pennsylvania, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 14. maj 2026 · NCT06222580

Massage Impact on Sleep in Pediatric Oncology

Vključevanje udeležencev
  • Children's Hospital of Philadelphia, Philadelphia
Starost 12–21 · Vsi spoli · Posodobljeno 15. apr. 2026 · NCT06892158

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Vključevanje udeležencevFaza 1/2
  • Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Starost 12 in več · Vsi spoli · Posodobljeno 24. mar. 2026 · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

Vključevanje udeležencevFaza 1/2
  • University of Pennsylvania, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 23. mar. 2026 · NCT04990102

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Vključevanje udeležencevFaza 1
  • Thomas Jefferson University Hospital, Philadelphia
Starost 12 in več · Vsi spoli · Posodobljeno 16. mar. 2026 · NCT06994676

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Vključevanje udeležencevFaza 1
  • Hospital of the University of Pennsylvania, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT05735184

Tazemetostat and Palbociclib With CPX-351for R/R AML

Vključevanje udeležencevFaza 1
  • Thomas Jefferson University Hospital, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT05627232

Home Blood Transfusions

Vključevanje udeležencev
  • Thomas Jefferson University Hospital, Philadelphia
Starost 18 in več · Vsi spoli · Posodobljeno 16. dec. 2025 · NCT07121140

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • University of Pennsylvania, Philadelphia
Starost 18–120 · Vsi spoli · Posodobljeno 25. jul. 2025 · NCT05237258

Študije za Akutna mieločna levkemija v drugih mestih

Druge študije v Philadelphia

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.